<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="119665">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01545063</url>
  </required_header>
  <id_info>
    <org_study_id>S54137</org_study_id>
    <nct_id>NCT01545063</nct_id>
  </id_info>
  <brief_title>CAre of Patients With PArenteral Nutrition At Home</brief_title>
  <acronym>CAPANAH</acronym>
  <official_title>Prospective Non-interventional Non-controlled Multicenter Observational Study to Evaluate the Quality of Care for Adult Patients on Home Parenteral Nutrition (HPN)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Katholieke Universiteit Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ziekenhuis Netwerk Antwerpen (ZNA)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>AZ Sint-Lucas</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universiteit Antwerpen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>AZ Sint-Blasius Dendermonde</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Imelda Hospital, Bonheiden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ziekenhuis Oost-Limburg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>AZ Damiaan, Oostende</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>H.-Hartziekenhuis Roeselare-Menen vzw</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universitair Ziekenhuis Brussel</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Ghent</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Jessa Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Katholieke Universiteit Leuven</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research aims to give an overview of a number of aspects related to the quality of care
      for adult patients on home parenteral nutrition.

      Concretely this study follows up different aspects on different moments in the care of the
      patient pathways:

        -  process indicators concerning indication, parenteral nutrition, training, team access
           roads and the succession of complications

        -  Outcome indicators

        -  the health-related quality of life

        -  discrepancies in medication use

        -  the role of the different health care providers
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Adult patients on HPN will be contacted by phone at three different time moments after their
      discharge to ask them about indicators, quality of life and discrepancies in medication use.
      After the follow-up, medical dossiers will be consulted to know which indicators are
      followed in practice.

      The role of the different health care providers will be investigated by face-to-face
      interviews with different healthcare professionals.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2012</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">May 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of life</measure>
    <time_frame>2 years</time_frame>
    <description>Quality of life will be investigated with the HPN-QoL(r) or FACIT-G (r).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of catheter related infections</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Crohn's Disease</condition>
  <condition>Peritoneal Carcinomatosis With Intestinal Occlusion</condition>
  <condition>Radiation Enteritis</condition>
  <condition>Chronic Diarrhea</condition>
  <condition>Intestinal Lymphomas</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Adult HPN patients with peritoneal carcinomatosis with intestinal occlusion or with
        crohn's disease, radiation enteritis, chronic diarrhea, intestinal lymphomas.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients in Flanders who speak Dutch, are older then 18 years and are able to give an
             informed consent.

        Exclusion Criteria:

          -  Patients who are younger then 18 years.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Antwerpen Middelheim</name>
      <address>
        <city>Antwerpen</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Els Verschueren, PharmD</last_name>
      <email>mira.dreesen@uzleuven.be</email>
    </contact>
    <investigator>
      <last_name>Els Verschueren, PharmD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UZA Antwerpen Edegem</name>
      <address>
        <city>Antwerpen</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hilde De Bosscher, PharmD</last_name>
      <email>mira.dreesen@uzleuven.be</email>
    </contact>
    <investigator>
      <last_name>Hilde De Bosscher, PharmD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Imelda Ziekenhuizen Bonheide</name>
      <address>
        <city>Bonheiden</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Freija Verbiest</last_name>
      <email>mira.dreesen@uzleuven.be</email>
    </contact>
    <investigator>
      <last_name>Freija Verbiest, PharmD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AZ Sint-Lucas</name>
      <address>
        <city>Brugge</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katrien Derouck, PharmD</last_name>
      <email>mira.dreesen@uzleuven.be</email>
    </contact>
    <investigator>
      <last_name>Katrien Derouck, PharmD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Centrum Brussel</name>
      <address>
        <city>Brussel</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kenny Noerens, PharmD</last_name>
      <email>mira.dreesen@uzleuven.be</email>
    </contact>
    <investigator>
      <last_name>Kenny Noerens, PharmD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AZ Sint Blasius Dendermonde</name>
      <address>
        <city>Dendermonde</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristien Claes</last_name>
      <email>mira.dreesen@uzleuven.be</email>
    </contact>
    <investigator>
      <last_name>Kristien Claes</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ziekenhuis Oost Limburg</name>
      <address>
        <city>Genk</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Evy Hendrickx</last_name>
      <email>mira.dreesen@uzleuven.be</email>
    </contact>
    <investigator>
      <last_name>Evy Hendrickx, PharmD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AZ Sint Lucas en Volkskliniek</name>
      <address>
        <city>Gent</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CÃ©line De Slooveren</last_name>
      <email>mira.dreesen@uzleuven.be</email>
    </contact>
    <investigator>
      <last_name>Celine De Sloovere, PharmD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UZ Gent</name>
      <address>
        <city>Gent</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hasselt Jessa Ziekenhuizen</name>
      <address>
        <city>Hasselt</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caroline Devolder, PharmD</last_name>
      <email>mira.dreesen@uzleuven.be</email>
    </contact>
    <investigator>
      <last_name>Caroline De Volder, PharmD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Catholic University</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mira Dreesen</last_name>
      <email>mira.dreesen@uzleuven.be</email>
    </contact>
    <investigator>
      <last_name>Ludo Willems, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AZ Damiaan</name>
      <address>
        <city>Oostende</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sabrina Commeyne, PharmD</last_name>
      <email>mira.dreesen@uzleuven.be</email>
    </contact>
    <investigator>
      <last_name>Sabrina Commeyne, PharmD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Heilig Hart vzw</name>
      <address>
        <city>Roeselare Menen</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beatrijs Deboutte, PharmD</last_name>
      <email>mira.dreesen@uzleuven.be</email>
    </contact>
    <investigator>
      <last_name>Beatrijs Deboutte, PharmD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>May 2012</verification_date>
  <lastchanged_date>May 25, 2012</lastchanged_date>
  <firstreceived_date>March 1, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Katholieke Universiteit Leuven</investigator_affiliation>
    <investigator_full_name>Mira Dreesen, PhD student</investigator_full_name>
    <investigator_title>PhD Student</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diarrhea</mesh_term>
    <mesh_term>Crohn Disease</mesh_term>
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Enteritis</mesh_term>
    <mesh_term>Intestinal Obstruction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
